Cat. No. 2771
Chemical Name: 4-(Diethylamino)-N-[7-(hydroxyamino
Biological ActivityHistone deacetylase inhibitor (IC50 = 100 nM). Induces terminal cell differentiation and causes an increase in hyperacetylated histone H4. Antiproliferative agent; suppresses the growth of human endometrial and ovarian cancer cells by inducing cell cycle arrest and apoptosis.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Riessland et al (2006) The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Hum.Genet. 120 101. PMID: 16724231.
Takai et al (2006) M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells. Gynecol.Oncol. 101 108. PMID: 16263156.
Jung et al (1999) Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. J.Med.Chem. 42 4669. PMID: 10579829.
If you know of a relevant reference for M 344 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses M 344 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: M 344, supplier, Histone, deacetylases, inhibitors, inhibits, HDAC, M344, epigenetics, Tocris Bioscience, Histone Deacetylase Inhibitor products